| | 82159-09-9 Basic information More.. |
| Product Name: | Epalrestat | | Synonyms: | 5-((1z,2e)-2-methyl-3-phenylpropenylidene)-4-oxo-2-thioxo-3-thiazolidineacet;e)-(e;EPALRESTAT;(e,e)-2-[5-(2-methyl-3-phenyl-prop-2-enylidene)-4-oxo-2-sulfanylidene-thiazo lidin-3-yl]acetic acid;AKOS BBS-00007767;OTAVA-BB BB7211260020;Epalrest;Epalrestat, 99.5% | | CAS: | 82159-09-9 | | MF: | C15H13NO3S2 | | MW: | 319.4 | | EINECS: | 675-018-0 | | Mol File: | 82159-09-9.mol |  |
Use
Epalrestat is the second aldose reductase inhibitor to be introduced worldwide and the
first to be launched in Japan. The compound is indicated for the treatment of diabetic
neuropathy. It is also being investigated for diabetic retinopathy and nephropathy.
- Epalrestat
-
- US $10.00 / kg
- 2024-04-24
- CAS:82159-09-9
- Min. Order: 1kg
- Purity: 99.8%
- Supply Ability: 10000ton
- Epalrestat
-
- US $10.00 / kg
- 2024-03-08
- CAS:82159-09-9
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg
|
|
82159-09-9
Recommend Suppliers |
|